Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
19.86
+0.45 (2.29%)
Sep 3, 2026, 1:04 PM EDT - Market open
Beta Bionics Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Beta Bionics stock has a consensus rating of "Buy" and an average price target of $20.31. The average 1-year stock price forecast is 2.27% higher than the current stock price, while the lowest is $14 (-29.51%) and the highest is $30.4 (+53.07%).
Price Target: $20.31 (+2.27%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Beta Bionics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Aug 21, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Reiterates $16 → $18 | Hold | Reiterates | $16 → $18 | -9.37% | Aug 11, 2026 |
| Ladenburg Thalmann & Co. | Ladenburg Thalmann & Co. | Buy Reiterates $30 | Buy | Reiterates | $30 | +53.07% | Jul 30, 2026 |
| Lake Street | Lake Street | Buy Reiterates $20 | Buy | Reiterates | $20 | +0.70% | Jul 30, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates $22 | Buy | Reiterates | $22 | +10.78% | Jul 30, 2026 |
Financial Forecast
Revenue This Year
133.88M
from 100.25M
Increased by 33.55%
Revenue Next Year
179.65M
from 133.88M
Increased by 34.19%
EPS This Year
-1.90
from -1.38
EPS Next Year
-2.32
from -1.90
EPS and Forward PE are based on non-GAAP adjusted numbers.